Podcasts about Health economics

Dr. Frank Leone is a Professor of Medicine in the Perelman School of Medicine, University of Pennsylvania. He directs Penn's Comprehensive Smoking Treatment Program, offering multidisciplinary collaborative patient care to people suffering complex manifestations of tobacco use disorder. Dr. Leone is a Senior Fellow of the Leonard Davis Institute of Health Economics. His scholarship focuses on investigating advanced treatment strategies for tobacco use disorder and on testing strategies for improving the care of the tobacco dependent patient. Dr. Leone has published over 130 peer-reviewed papers and, along with Ms. Evers-Casey, has co-authored a clinical handbook of tobacco dependence treatment titled Why People Smoke: An Innovative Approach to Treating Tobacco Dependence. Today on the show we discuss: why vaping isn't actually safer than cigarettes, how vape aerosols damage your lungs and heart even without traditional carcinogens, the hidden addiction mechanics that make nicotine one of the hardest habits to break, why vaping increases anxiety, depression, and the risk of other substance addictions, how to finally quit vaping for good  proven strategies, how parents and loved ones can help without judgment or shame and much more. ⚠ WELLNESS DISCLAIMER ⚠ Please be advised; the topics related to health and mental health in my content are for informational, discussion, and entertainment purposes only. The content is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek the advice of your health or mental health professional or other qualified health provider with any questions you may have regarding your current condition. Never disregard professional advice or delay in seeking it because of something you have heard from your favorite creator, on social media, or shared within content you've consumed. If you are in crisis or you think you may have an emergency, call your doctor or 911 immediately. If you do not have a health professional who is able to assist you, use these resources to find help: Emergency Medical Services—911 If the situation is potentially life-threatening, get immediate emergency assistance by calling 911, available 24 hours a day. National Suicide Prevention Lifeline, 1-800-273-TALK (8255) or https://suicidepreventionlifeline.org.  SAMHSA addiction and mental health treatment Referral Helpline, 1-877-SAMHSA7 (1-877-726-4727) and https://www.samhsa.gov Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome back to this explainer on health economics analyses in musculoskeletal rehabilitation. In part 1, Dr Codie Primeau explained the things you're looking for when reading a health economics analysis, to decide whether it's a good quality analysis. That's important because a good quality analysis can help you make decisions about whether the intervention being studied is worth considering. Today in part 2, we take things a step further to explore how you decide what "worthwhile" really means. Worth it for whom? The patient, your clinic, the health system, or even society? ------------------------------ RESOURCES From whose perspective is cost-effectiveness judged?: https://pmc.ncbi.nlm.nih.gov/articles/PMC6351264/ Review of health economics evaluations in hip and knee orthopaedics: https://pubmed.ncbi.nlm.nih.gov/34262974/

Whether you work in a solo private practice, or a large health network, no doubt you're considering costs when it comes to deciding what to change and perhaps what to implement - or de-implement - in your practice. Perhaps you're in the position of making decisions on behalf of a health service or you are trying to quantify and communicate the costs and benefits of treatments you study in a research setting? Today is part 1 of a 2-part chat with Dr Codie Primeau about health economics in musculoskeletal rehabilitation, which has something for everyone working in health care. We're covering how to read a health economics analysis to decide whether the analysis can help you navigate the complex decisions you're grappling with. Dr Primeau is a physiotherapist and Assistant Professor in the School of Physical Therapy at Western University in London, Canada, and an Affiliate Scientist with Arthritis Research Canada. His research focuses on arthritis, chronic pain, and pelvic health, using a blend of qualitative and quantitative methods to improve patient care and outcomes, including health economics evaluation. ------------------------------ RESOURCES From whose perspective is cost-effectiveness judged?: https://pmc.ncbi.nlm.nih.gov/articles/PMC6351264/ Review of health economics evaluations in hip and knee orthopaedics: https://pubmed.ncbi.nlm.nih.gov/34262974/

On this episode of Alloutcoach, host Tim Mikhelashvili, CEO, Amedea Pharma convenes a panel you rarely hear in one room: a policy-minded biohacker and investor (John Hemming, CEO of Cirrostratus, Biohacking Team Leader), a strategy and operations leader who reshapes patient journeys (Bart Zoni, Senior Vice President, Marketing, Woven Health Collective), and an early-stage investor focused on medical technologies (Chris Piedmonte, Managing Director, Neoterra Capital) as well as a senior pharma thought leader in Medical Affairs and Health Economics, Janelle Hardisty. Their catalyst? Fresh takeaways from the 2025 Financial Times US Pharma summit — and an honest look at what's truly accelerating innovation, what's stalling it, and where capital and talent should go next.00:00:00 Cold Open - Episode Highlights: AI accuracy and access00:03:43 Host Intro and Why This Episode00:04:41 Guest Intros00:08:06 State of Innovation - Tailwinds and Headwinds00:12:41 What's Really Accelerating Innovation?00:19:27 Drug Discovery - Reducing the 90% Failure Rate00:22:01 Clinical Trials - Modernize or Stall00:25:11 Access, PBMs, and Direct-to-Patient00:27:03 Longevity and Prevention - Can We Measure It?00:36:52 Data Culture Maturity and Pilot Fatigue00:45:52 Training the Future Workforce00:51:09 Investing - Where Should Capital Flow?00:57:08 Regulatory Reality and Time-to-Access00:59:27 Closing and Invite to Medical Innovation Olympics

AJ is joined by Dr. Jason Aziz, Director of Health Economics at the New Hampshire Insurance Department and Adjunct Lecturer at The Friedman School of Nutrition Science and Policy at Tufts University. They discuss the role of public health, the lessons from COVID, and how fixing its public perception will lead to better outcomes. Let's get back to original MAHA!

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial payers. HEOR, viewed as a strategic lever as opposed to a compliance exercise, can help answer investor questions about market differentiation, pricing pathways, and real world product validation. Abbott talks about the value of cost-of-illness studies, burden-of-disease analyses, and payer landscape assessments, and how AI, real world evidence, and patient-centered research can improve drug and trial design and accelerate market access.       Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

 Today we joined by Jon Gordon, a visionary, thinker, and innovator working at the crossroads of healthcare, finance and consciousness. Jon brings over a decade of experience in the healthcare industry, spanning strategy consulting for hospitals and health systems, payer business strategy, medical product management, and startup development, while also being deeply rooted in yoga.Holistic wellness and the emerging paradigm of decentralized finance. Jon is a graduate of Northwestern University with a BA in Economics, and he went on to earn a double Master's in Health Economics and Policy at both the University of Chicago and the London School of Economics. Alongside his academic and professional expertise, Jon is also a certified Himalayan Kriya yoga teacher and an author exploring the profound connections between Bitcoin and yoga.For the past four years, Jon has immersed himself in the Bitcoin space, not just as a student of financial systems, but as a community builder and Austin's vibrant Bitcoin scene. He also has co-founded two ventures at the intersection of Bitcoin and healthcare, re-imagining how money and medicine can work together for collective wellbeing.This conversation, Jon and Sasha explore: The 80-year cycle of finance and the lessons it offers us today Bitcoin as a decentralized store of value and a potential game changer for time, health, and human empowermentHow embracing change and deepening financial literacy can help us prepare for the future of currencyThe integration of Bitcoin into healthcare, including Ayurveda, Yoga teacher trainings and other holistic practices People may want to invest in the vision of a new paradigm where money and health merge, creating a reality where value exchange supports both healing and human flourishing. This is a powerful conversation at the frontier of Ayurveda, yoga, and financial evolution; a reminder that the way we think about money is inseparable from the way that we think about our health, our time, and our freedom. Send us a textFor 20% off Kerala Ayurveda products, use code OjasOasis at checkoutFor 20% off GarryNSun products, use code OJASOASIS20 at checkout Book a 1:1 with Sasha at https://www.ojasoasis.com/book For 50% off your initial intake consultation, mention you're a subscriber of the podcast. Support the showTo learn more about working with us, please visit www.OjasOasis.com Connect with us @ojasoasis on Instagram

What happens when a single bill threatens to leave 10+ million Americans uninsured and hospitals on the brink?In this episode, host Dr. Bradley Block reunites with Adam Block, PhD, to break down Trump's sweeping healthcare legislation, HR 1—dubbed the "big beautiful bill"—which consolidates multiple reforms into one massive package. He explains how indirect measures like increased paperwork, monthly re-enrollments, and work requirements will lead to 10+ million losing Medicaid and ACA coverage, without direct cuts. The discussion covers fraud, waste, and abuse in Medicaid, the role of AI in filling government gaps, and the bill's delayed rollout post-midterms. They also explore site-neutral payments' effects on hospitals and ambulatory centers, cross-subsidization for safety-net services, and why hospitals' razor-thin margins make them vulnerable. This episode is crucial for healthcare professionals preparing for higher uncompensated care, sicker patients, and systemic shifts in reimbursement and access.Three Actionable Takeaway:Monitor Policy Changes Closely – Stay informed on Medicaid work requirements and ACA enrollment shifts rolling out in 2027. Review your practice's payer mix and prepare for increased uninsured patients by advocating for state-level expansions or adjustments.Advocate for Your Practice – If you own or operate ambulatory surgery centers, assess the impact of site-neutral payments. Engage with hospital associations to push for subsidies that maintain safety-net services, ensuring cross-subsidization doesn't erode entirely.Prepare for Operational Strain – Anticipate higher uncompensated care and sicker presentations. Build contingency plans like AI-assisted administrative tools or partnerships with community resources to handle paperwork burdens and support vulnerable patients.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Adam Block is a Harvard-trained health economist with over two decades of experience at the intersection of healthcare policy, hospitals, and insurance. He played a key role in drafting sections of the Affordable Care Act for Congress and writing foundational regulations for the Centers for Medicare & Medicaid Services (CMS) to establish health insurance exchanges. After five years in data analytics roles reporting to CFOs, he founded Charm Economics, a consulting firm focused on health economics, and serves as an associate professor of public health at New York Medical College. Dr. Block's expertise lies in navigating complex policy changes, reimbursement challenges, and systemic healthcare shifts, offering critical insights for physicians and providers.LinkedIn: linkedin.com/in/adameblockEmail: adam@charmeconomics.comWebsite: https://www.charmeconomics.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance.

Send us a textLast month, The Lancet posted online an article from Stine Johansen, Fredrik Åberg, Emmanuel Tsochatzis and Aleksander Krag, titled "Screening for Advanced Liver Disease." The article aims to update the Wilson and Jungner criteria, initially developed in 1960, to address modern needs and issues. In this conversation, Professor Krag and Dr. Johansen join Roger Green to discuss their article. There are many nuances and high points to cover in this thoughtful, fairly lengthy conversation, but one key point is that screening a mass population for HCC or cirrhosis has an entirely different set of issues and criteria compared to the screening usually discussed on this podcast, which involves identifying a population at increased risk for MASLD or MASH and screening them. Also, healthcare is far more expensive than it was in 1960 with a plethora of high-cost ways to diagnose, treat and manage patients.As a result, the authors started with the 10 Wilson and Jungner criteria and added eight more. During this conversation, Stine emphasizes the need for a comprehensive clinical trial on this issue, and all panelists agree that LiverAIM is likely to serve as the study.

Send us a text00:00:00 - Surf's Up: Season 6 Episode 13 Louise Campbell, Jörn Schattenberg and Roger Green continue their discussion of some major issues from earlier this year, while co-authors Aleksander Krag and Stine Johanset join Roger to discuss their recent publication in The Lancet, titled "Screening for Advanced Liver Disease." 00:04:45 - Major Issues of the First Six Months: Integrated Patient ManagementLouise drives this conversation based on two related issues she sees emerging: (i) increasing opportunities for motivated patients to manage their own health and (ii) managing the total patient in an environment where people may be taking incretin agonists as if they are consumer drugs. With increased access to scanning, providers can monitor patients (and patients can self-monitor) more closely. However, some of the issues a provider might find are tricky: patients who undertake what Louise describes as "the sneaky areas patients think are normal, but are probably contributing to disease" due to miseducation or no education on healthy eating and lifestyle, or patients purchasing and using incretin agonists through consumer channels, but possibly at subtherapeutic doses. Vigilance and probing are key here, but health systems will need to train more people on the types of probing that uncover underlying issues and behaviors that patients mistakenly believe to be healthy. 00:21:02 - Newsmakers: Aleksander Krag and Stine Johansen discuss Screening for Advanced Liver DiseaseLast month, The Lancet posted online an article from Stine Johansen, Fredrik Åberg, Emmanuel Tsochatzis and Aleksander Krag, titled "Screening for Advanced Liver Disease." The article aims to update the Wilson and Jungner criteria, originally developed in 1960, to address modern needs and issues. In this conversation, Professor Krag and Dr. Johansen join Roger Green to discuss their article. There are many nuances and high points to cover in this thoughtful, fairly lengthy conversation, but the key point is that screening a mass population for HCC or cirrhosis has an entirely different set of issues and criteria compared to the screening usually discussed on this podcast, which involves identifying a population at increased risk for MASLD or MASH and screening them. 00:54:42 - Major Issues of the First Six Months: Changes in US Health Policy and Potential for Dynamism in the In-Office Scanning Market Roger drives this conversation, focusing on two very different, yet very important issues: the first is the increasing dynamism of the in-office scanning market, with leader Echosens developing new products and services, while companies like e-Scopics, Sonic Incytes, and Mindray (Hepatus) are introducing new devices with competing profiles. Roger discusses the idea that some scanners keep all data resident in the machine, while others send it immediately to the cloud. Louise suggests that we should welcome any reliable scanning device to the market. Separately, he lists some concerns about how the Trump Administration's focus on cutting services to the poor, coupled with Robert F. Kennedy Jr.'s distrust of pharmaceuticals and mainstream health research, might limit the number of Americans with access to healthcare and the kinds of care they can access. At the end of this conversation, Roger asks Jörn and Louise what they consider major issues for the next six months.01:11:40 - Business Report and Wrap-Up

In this Vital Health Podcast, host Duane Schulthess speaks with two leading European voices on oncology and health economics: Andreas Charalambous: Chair of Nursing at Cyprus University and Executive Board Member at MASCC, former President of the European Cancer Organization, Director of the Research Center for Oncology and Palliative Care at eOncoRise Lieven Annemans: Professor of Health Economics at Ghent University, past President of ISPOR Together, they unpack why the EU’s Beating Cancer Plan and Cancer Mission remain only partially implemented and what it will take to turn commitments into action. Key Topics Centralized vs. National Action: Why Europe still needs coordinated cancer strategies alongside national execution, and how fragmentation drives inertia. Costs, Rarity, and Value: The economics of small patient populations, return on investment, and why rare cancers demand inclusion in national plans. Prevention & Early Detection: How shifting budgets from treatment to prevention and screening offers long-term impact but little short-term political payoff. Equity & Access: Unequal survival rates between and within EU member states, limited medicine availability in countries like Greece, and the role of patient engagement. Data & Accountability: Calls for plan-do-check-act cycles, stronger measurement, and better digital health training for Europe’s cancer workforce. Financing & Long-Term Policy: Whether EU-level financing instruments should support health infrastructure, and why tackling social and commercial determinants could reshape outcomes over decades. This episode offers a candid look at the complexity of cancer policy in Europe, exploring prevention, financing, innovation, and political realities that will define cancer care over the next decade. Opinions expressed are those of the speakers, not the institutions listed. Podcast created with the support of Merck Sharp & Dohme. Recorded July 2025.See omnystudio.com/listener for privacy information.

Dr. Christiane Schroeter is a TEDx speaker, bestselling author, and Business & Wellness Coach who helps entrepreneurs achieve extraordinary results with small, strategic actions. With a Ph.D. in Health Economics, she is a Professor of Marketing, Innovation, and Entrepreneurship at a top U.S. university and has earned international recognition for her research and teaching.She is the host of the Happy Healthy Hustle Podcast—ranked in the Top 1% globally—where she shares high-performance strategies that blend productivity, business growth, and well-being. Her no-fluff, high-energy style makes her a memorable and practical guest for purpose-driven audiences.Christiane is the author of three books, including the Amazon #1 bestseller How to Master Your Goals. Her signature Petite Practice™ framework, featured in her latest releases Discover Your Superpower and the Petite Practice™ Planner, empowers entrepreneurs to work smarter, scale faster, and lead with clarity. A sought-after keynote speaker, she delivers actionable insights designed to spark meaningful transformation.

Best-selling author, speaker & creator of “The PetitePractice” Dr. Christiane Schroeter talks about her releases “Discover YourSuperpower” and “How to Master Your Goals” helping professionals andentrepreneurs unlock their unique strengths & create success on their ownterms! Dr. Schroeter began her career moving from Germany to the U.S. in '99while earning her degrees in Health Economics and Agribusiness, began “The PetitePractice” as a way to grow honoring your energy, season, and pace; plusexplains the 3P System and how to stop overthinking & start making progresswhile taking action and building confidence creating momentum in your life andcareer! Check out the amazing Dr. Christiane Schroeter and her latest releaseon all major platforms and www.doctorchristiane.comtoday! #podmatch #drchristianeschroeter #author #creator #thepetitepractice#discoveryoursuperpower #howtomasteryourgoals #professionals #enterpreneurs#economics #agriculture #germany #3Psystem #energy #spreaker #iheartradio#spotify #applemusic #youtube #anchorfm #bitchute #rumble #mikewagner#themikewagnershow #mikewagnerdrchristianeschroeter #themikewagnershowdrchristianeschroeter

Best-selling author, speaker & creator of “The PetitePractice” Dr. Christiane Schroeter talks about her releases “Discover YourSuperpower” and “How to Master Your Goals” helping professionals andentrepreneurs unlock their unique strengths & create success on their ownterms! Dr. Schroeter began her career moving from Germany to the U.S. in '99while earning her degrees in Health Economics and Agribusiness, began “The PetitePractice” as a way to grow honoring your energy, season, and pace; plusexplains the 3P System and how to stop overthinking & start making progresswhile taking action and building confidence creating momentum in your life andcareer! Check out the amazing Dr. Christiane Schroeter and her latest releaseon all major platforms and www.doctorchristiane.comtoday! #podmatch #drchristianeschroeter #author #creator #thepetitepractice#discoveryoursuperpower #howtomasteryourgoals #professionals #enterpreneurs#economics #agriculture #germany #3Psystem #energy #spreaker #iheartradio#spotify #applemusic #youtube #anchorfm #bitchute #rumble #mikewagner#themikewagnershow #mikewagnerdrchristianeschroeter #themikewagnershowdrchristianeschroeter

Best-selling author, speaker & creator of “The Petite Practice” Dr. Christiane Schroeter talks about her releases “Discover Your Superpower” and “How to Master Your Goals” helping professionals and entrepreneurs unlock their unique strengths & create success on their own terms! Dr. Schroeter began her career moving from Germany to the U.S. in '99 while earning her degrees in Health Economics and Agribusiness, began “The Petite Practice” as a way to grow honoring your energy, season, and pace; plus explains the 3P System and how to stop overthinking & start making progress while taking action and building confidence creating momentum in your life and career! Check out the amazing Dr. Christiane Schroeter and her latest release on all major platforms and www.doctorchristiane.com today! #podmatch #drchristianeschroeter #author #creator #thepetitepractice #discoveryoursuperpower #howtomasteryourgoals #professionals #enterpreneurs #economics #agriculture #germany #3Psystem #energy #spreaker #iheartradio #spotify #applemusic #youtube #anchorfm #bitchute #rumble #mikewagner #themikewagnershow #mikewagnerdrchristianeschroeter #themikewagnershowdrchristianeschroeterBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-mike-wagner-show--3140147/support.

Camidge and Lee discussed Lee's professional journey and personal insights gained from years of working at the intersection of clinical research and patient care. 

Health is one of the biggest economic and societal issues in the U.S., and the conversation around vaccines has never been more complex—or more personal.Board-Certified Pediatrician Dr. Brian Thornburg joins Futures Edge with Jim Iuirio and Bob Iaccio to guide parents through the evolving world of vaccines and children's healthcare. From the impact of COVID-19 on vaccine perceptions to the rise of mRNA technology, Dr. Thornburg breaks down why being an informed parent has never been more crucial.In this episode, you'll learn:- How COVID-19 reshaped trust in vaccines and fueled hesitancy- Why evaluating each vaccine individually matters more than ever- The vital role of nutrition in childhood growth and long-term health- How Big Pharma influences public health policies and vaccine guidelines- Practical ways parents can take charge of their children's healthcare decisionsTIMESTAMPS: 00:00 Introduction and Housekeeping01:26 The Economic Impact of Health03:07 Vaccine Hesitancy and COVID-1904:38 Understanding Vaccine Schedules07:44 The Role of Parents in Vaccine Decisions09:31 Long-term Effects of COVID-19 and Vaccines11:06 Vaccine Neutrality and Patient Autonomy12:56 The Evolution of Vaccine Perspectives17:23 Global Vaccine Perspectives21:49 The Influence of Big Pharma on Vaccination Policies26:49 The Influence of Big Pharma28:21 Understanding Vaccines: Definitions and Misconceptions32:33 The Immune System and Vaccination Timing35:10 Toxins in Vaccines and Their Impact41:32 Long-term Safety and Vaccine Concerns43:08 RFK's Role in Vaccine Discussion44:35 Nutrition's Role in Child Health48:53 The Standard American Diet and Its Effects

What does it really take to start over and build something entirely your own?In this episode of Women Leaders on the Move, Nancy Hedlund talks with host Natalie Benamou and shares how she returned to grad school in her 40s, being a mom of 4 children. Nancy knew that having the added expertise would advance her career. As Founder and Managing Director of MedNavigate LLC, Nancy helps life science companies bring new innovations to market. Her story is one of clarity, resilience, and bold reinvention.“It's not about having the whole plan; it's about being willing to take the next step with purpose.” – Nancy HedlundKey Takeaways:How to Navigate career changes with confidenceWhat it takes to balance family, school, and full-time workReimagined success on her own terms and how to build a business grounded in expertise and intention“It's not about having the whole plan—it's about being willing to take the next step with purpose.” – Nancy HedlundThis conversation is part of the Power of What's NEXT : Bold Moves By Design author series, featuring the authors who are redefining their future.✨ Ready to make your own bold move?Start your next chapter with inspiration and clarity.

The One Big Beautiful Bill Act is projected to cut Medicaid spending by more than $1 trillion. The law changes eligibility rules, and some predictions estimate at least 10.5 million people will be eliminated from the program. “For some adults, Medicaid will step in and help pay for care at home, or if care at home is not available, for care in nursing homes,” said Rachel Werner, executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. “With the cuts to Medicaid funding, we are expecting that the availability of care in both of those settings will diminish, and it will be harder for people to get the care they need to live independently.” States will have to respond to the changes by either making up the funding gap or reducing services. On the show today, Werner explains how the funding cuts could limit the caregiving options for older Americans who need at-home care and place a larger responsibility on their families. Plus, we discuss how to start planning for long-term care amid all the legislative changes.Then, we'll celebrate a listener's win about her chocolate lab puppy. And, another listener's quest to find life on Mars.Here's everything we talked about today:“How Medicaid Cuts Could Force Millions Into Nursing Homes” from The Leonard Davis Institute of Health Economics at the University of Pennsylvania“Advocates warn that Medicaid cuts in the big budget law put home-based health care at risk” from Marketplace“New AARP Report: Majority of Adults 50-plus Want to Age in Place, But Policies and Communities Must Catch Up” from AARP“A Closer Look at the Medicaid Work Requirement Provisions in the “Big Beautiful Bill” from KFF“Medicaid cuts: The how and why” from the newsletter Your Local Epidemiologist“As the need for nursing homes grows, nurses are in short supply” from MarketplaceWe love hearing from you. Leave us a voicemail at 508-U-B-SMART or email makemesmart@marketplace.org.

The One Big Beautiful Bill Act is projected to cut Medicaid spending by more than $1 trillion. The law changes eligibility rules, and some predictions estimate at least 10.5 million people will be eliminated from the program. “For some adults, Medicaid will step in and help pay for care at home, or if care at home is not available, for care in nursing homes,” said Rachel Werner, executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. “With the cuts to Medicaid funding, we are expecting that the availability of care in both of those settings will diminish, and it will be harder for people to get the care they need to live independently.” States will have to respond to the changes by either making up the funding gap or reducing services. On the show today, Werner explains how the funding cuts could limit the caregiving options for older Americans who need at-home care and place a larger responsibility on their families. Plus, we discuss how to start planning for long-term care amid all the legislative changes.Then, we'll celebrate a listener's win about her chocolate lab puppy. And, another listener's quest to find life on Mars.Here's everything we talked about today:“How Medicaid Cuts Could Force Millions Into Nursing Homes” from The Leonard Davis Institute of Health Economics at the University of Pennsylvania“Advocates warn that Medicaid cuts in the big budget law put home-based health care at risk” from Marketplace“New AARP Report: Majority of Adults 50-plus Want to Age in Place, But Policies and Communities Must Catch Up” from AARP“A Closer Look at the Medicaid Work Requirement Provisions in the “Big Beautiful Bill” from KFF“Medicaid cuts: The how and why” from the newsletter Your Local Epidemiologist“As the need for nursing homes grows, nurses are in short supply” from MarketplaceWe love hearing from you. Leave us a voicemail at 508-U-B-SMART or email makemesmart@marketplace.org.

On June 18, Tradeoffs moderated an online event with economists and doctors examining why this legislation could cost so many people their health coverage — or even their lives.Guests:Eric Roberts, Associate Professor, Department of General Internal Medicine, Perelman School of MedicineAditi Vasan, Assistant Professor, Department of Pediatrics, Perelman School of MedicineRachel Werner, Executive Director, Leonard Davis Institute of Health Economics, University of PennsylvaniaLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Israel's strike on Iran. Assassination of a Minnesota politician. Economics of aging.  Find us on YouTube. Mike and Clarissa discuss the complex backdrop of Israel's strikes on Iran, the assassination of a Minnesota politician, and a Christian response to political violence. Then, Clarissa sits down with economist Sita Slavov to discuss economic issues related to aging, including social security policy and wisdom for retirement.  GO DEEPER WITH THE BULLETIN: Join the conversation at our Substack. Find us on YouTube. Rate and review the show in your podcast app of choice. ABOUT THE GUESTS:  Sita Slavov is a professor of public policy at the Schar School of Policy and Government at George Mason University, a faculty research fellow at the National Bureau of Economic Research, and a senior fellow at the American Enterprise Institute. She specializes in public finance and the economics of aging. Sita has served as a senior economist specializing in public finance issues at the White House's Council of Economic Advisers, and she has testified before Congress. Her work has appeared in peer-reviewed journals such as the Journal of Health Economics and the Journal of Public Economics. She also has work published in The New York Times, Los Angeles Times, RealClearPolicy, and US News & World Report. ABOUT THE BULLETIN: The Bulletin is a twice-weekly politics and current events show from Christianity Today moderated by Clarissa Moll, with senior commentary from Russell Moore (Christianity Today's editor in chief) and Mike Cosper (director, CT Media). Each week, the show explores current events and breaking news and shares a Christian perspective on issues that are shaping our world. We also offer special one-on-one conversations with writers, artists, and thought leaders whose impact on the world brings important significance to a Christian worldview, like Bono, Sharon McMahon, Harrison Scott Key, Frank Bruni, and more. The Bulletin listeners get 25% off CT. Go to https://orderct.com/THEBULLETIN to learn more. “The Bulletin” is a production of Christianity Today Producer: Clarissa Moll Associate Producer: Alexa Burke Editing and Mix: Kevin Morris Music: Dan Phelps Executive Producers: Erik Petrik and Mike Cosper Senior Producer: Matt Stevens Learn more about your ad choices. Visit podcastchoices.com/adchoices

Send us a textThe obsession with calculating the "cost of ob*sity" to society reflects our troubling tendency to commodify human life and health. In this rather ragey and explosive episode, I expose how a widely-cited figure of £98 billion was manufactured by pharmaceutical interests to sell weight loss drugs. I challenge the notion that we "owe" society a debt of health and explore how weight stigma, not weight itself, drives depression and poor health outcomes. Through a rather provocative thought experiment, I reveal the absurdity of reducing human experience to economic calculations and argue that tackling stigma, not eradicating fatness, is the real path forward. Today's journal article was:  Stevens, Serena D et al. “Adult and childhood weight influence body image and depression through weight stigmatization.” Journal of health psychology vol. 22,8 (2017): 1084-1093. doi:10.1177/1359105315624749 Got a question for the next podcast? Let me know! Connect With Me FREE GUIDES: evidence-based, not diet nonsense NEWSLETTER: Life-changing insights straight to your inbox UNSHRINKABLE: Find out why your body is not designed to shrink MASTERCLASSES: All the evidence doctors should give you NO WEIGH PROGRAM: Join the revolution against weight-loss lies THE WEIGHTING ROOM: A community where authenticity thrives and every voice matters CONSULTATION: For the ultimate transformation in your healthcare journe Find me on Instagram, YouTube, and LinkedIn.

(02:00): Zelenskyj vil have Trump med til fredsforhandlinger - fordele og ulemper? Medvirkende: Stefan Weichert, journalist i Ukraine. (11:00): Trump langer ud efter Novo Nordisk og lover lavere medicinpriser. Medvirkende: Lars Holger Ehlers, tidligere professor i sundhedsøkonomi, i dag direktør i Nordic Institute of Health Economics. (30:00): Børns Vilkår: Det er vigtigt, at præster underretter, når de hører om svigtede børn. Medvirkende: Anne Kappelgaard Bové, seniorkonsulent, Børns Vilkår. Værter: Anne Philipsen & Nicolai DandanellSee omnystudio.com/listener for privacy information.

(00:00): Ekspert analyserer Ukraine og Ruslands tilsyneladende tilnærmelser. Medvirkende: Flemming Splidsboel Hansen, seniorforsker hos DIIS med speciale i Rusland og det postsovjetiske område. (13:00): PKK opløses og den væbnede kamp mod Tyrkiet indstilles. Medvirkende: Deniz Serinci, forfatter med speciale i de tyrkiske forhold. (30:00): USA og Kina sætter dele af toldkrigen på pause i 90 dage. Medvirkende: Rune Møller Stahl, Senioranalytiker ved Oxfam Danmark, der tidligere har forsket i international politisk økonomi ved CBS. (37:00): Trump vil sænke prisen på lægemidler med 30-80 procent i USA. Medvirkende: Lars Holger Ehlers, tidligere professor i sundhedsøkonomi, i dag direktør i Nordic Institute of Health Economics. Værter: Anne Phillipsen og Nicolai Dandanell See omnystudio.com/listener for privacy information.

ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR), takes place 13th-16th May and marks the 30th anniversary of the organisation. Ahead of the event, web editor Nicole Raleigh spoke with Rob Abbott, CEO and executive director of ISPOR – the leading professional society for HEOR globally – about the ins and outs and trends of HEOR. ISPOR's mission is to advance HEOR excellence to improve decision making for health globally, and Abbott explains its focus on the value of particular healthcare interventions, the impact on the quality of life of patients, and how his work is centred around positioning HEOR as a key lever for decision makers and shapers globally to create a world in which healthcare is accessible, effective, efficient, and affordable for everyone. You can listen to episode 177a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, Amazon Music, Podbean, and pretty much wherever you get your other podcasts!

Are tax hikes really driving up illicit trade, or is the industry narrative just smoke and mirrors? Professor Corné van Walbeek, Director of UCT’s Research Unit on the Economics of Excisable Products (REEP), joins John Maytham to unpack key insights into why beer consumption is thriving despite tax increases, how Treasury’s tiered alcohol tax model is encouraging healthier choices, and why South Africa is losing billions each year to illicit cigarettes. It is a data-driven deep dive into the numbers, the narrative, and the policy path forward.See omnystudio.com/listener for privacy information.

About this episode: As a follow up to our recent episode titled The Potential Impacts of Cuts To Medicaid, we're partnering with our friends at the Tradeoffs podcast. Guest hosts Dan Gorenstein and Ryan Levi, longtime health reporters, take a deeper look at why many Republicans believe a smaller Medicaid program would be a better Medicaid, what proposed cuts might look like, and the challenges Republicans may face in trying to get cuts passed in Congress. Guests: Dan Gorenstein is the executive producer and host of the Tradeoffs Podcast and an adjunct senior fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania.   Ryan Levi is a reporter and producer for the Tradeoffs Podcast. Show links and related content: Why Many Republicans Think Shrinking Medicaid Will Make It Better—Tradeoffs The Potential Impacts of Cuts To Medicaid—Public Health On Call (March 2025) The Oregon Experiment—Effects of Medicaid on Clinical Outcomes—The New England Journal of Medicine (2013) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Today, we are joined by Dr. Kathy Pearson and Dr. Gregg Pearson.Dr. Kathy Pearson, strategist, systems thinking expert, and decision-making authority, is President and Founder of Enterprise Learning Solutions. She is also an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics and has served as an adjunct Associate Professor in the Operations and Information Management Department at The Wharton School, both at the University of Pennsylvania. Kathy, an award-winning educator, collaborates with Executive Education groups and global organizations across industries like healthcare, finance, and technology, including clients such as Bank of America and Coca-Cola. She holds a BS in theoretical mathematics (Auburn University), an MS in Decision Sciences (Georgia State University), and a PhD in Industrial Engineering (Northwestern University).Dr. Gregg Pearson is a Partner at ELS and an Adjunct Professor of History at Lehigh University and La Salle University. He specializes in nineteenth-century American political history, twentieth-century American cultural history, military history, the history of technology, and business leadership. Gregg spent 16 years in the packaging industry, including as Northeast Region General Manager at Ball Corporation, overseeing $350M in revenue. He holds a PhD in History from Lehigh University, an MA from La Salle University, an MS in Industrial Engineering from Northwestern University, and is a graduate of the United States Military Academy at West Point.In this episode, we explore how Kennedy evolved as a leader, learning from earlier failures to develop a more effective crisis management approach that became the gold standard for leadership under extreme pressure.Key topics include:• How Kennedy's approach evolved from the Bay of Pigs failure to the Cuban Missile Crisis• The critical importance of gathering reliable information before making decisions• Why seeking contrary viewpoints helps leaders avoid confirmation bias• How clear "commander's intent" empowers teams to adapt in changing circumstances• The value of structured post-mortems to learn from both successes and failures-Website and live online programs: http://ims-online.comBlog: https://blog.ims-online.com/Podcast: https://ims-online.com/podcasts/LinkedIn: https://www.linkedin.com/in/charlesgood/Twitter: https://twitter.com/charlesgood99Chapters:(00:00) Introduction(02:00) Setting the Historical Context(04:40) Technique: Avoiding Confirmation Bias in Leadership(07:00) Tip: Making Decisions with Incomplete Information(09:00) Kennedy's Evolution as a Leader(12:00) Tool: The Role of Objective Information in Crisis(16:00) Tip: The Power of Clear Purpose in Uncertain Times(20:40) Tip: Learning from Failure to Improve Decision-Making(25:00) Technique: The Art of Compromise in Leadership(28:00) Tool: Military After-Action Reviews in Business Context(31:00) Conclusion

The Minds in Motion Podcast from Dementia Researcher in association with the NIHR Applied Research Collaborations and Alzheimer's Society, brings together NIHR Dem Comm Research Fellows, to talk about their research and careers. In this second series, we hear from five of the Dem Comm Fellows each taking a turn as co-host and guest. Alongside the researchers we have the incredible Trevor Salomon, Alzheimer's Society Volunteer & Chair of the European Dementia Carers Working Group as our permanent co-host and anchor. In show Trevor is joined by the guest from our previous show Dr Lis Grey from University of Bristol and the NIHR Applied Research Collaboration (ARC) West to interview Dr Katie Breheny. Katy works in the NIHR ARC West and University of Bristol. Katie is a health economist focused on improving the way we assess and value healthcare interventions for people living with dementia. Her research explores how traditional health economic methods can be adapted to better capture wellbeing and quality of life in dementia care. With a background in psychology, Katie's work spans health economics, patient-reported outcomes, and methodological research, ensuring that economic evaluations reflect the real-world needs of individuals, carers, and service providers. She is particularly interested in making assessments more inclusive and meaningful, while also working on innovative projects such as adapting wellbeing questionnaires and developing personalised digital tools to support dementia care. Dem Comm is a 2 year programme funded by the National Institute of Health and Care Research and the Alzheimer's Society. It supports a new generation of dementia research leaders, bringing together researchers from different multidisciplinary backgrounds to encourage cross-cutting and community-orientated dementia research projects that can address key gaps in the evidence around dementia care and support, delivering transformative translational research. For information on the Fellowship visit: http://www.arc-wx.nihr.ac.uk/dem-comm-research-fellows For guest biographies, a full transcript and much more visit: http://www.dementiaresearcher.nihr.ac.uk Like what you hear? Please review, like, and share our podcast, and don't forget to subscribe to ensure you never miss an episode. If you prefer to watch rather than listen, you'll find a video version of this podcast on our website, YouTube and Spotify. This podcast is brought to you in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support. Follow us on Social Media: http://www.instagram.com/dementia_researcher/ http://www.facebook.com/Dementia.Researcher/ http://www.bsky.app/profile/dementiare…archer.bsky.social http://www.linkedin.com/company/dementia-researcher

This episode has three chapters. Each one answers a key question, and, bottom line, it all adds up to action steps directly and indirectly for many, including plan sponsors probably, community leaders, and also hospital boards of directors. Here's the three chapters in sum. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Chapter 1: Are commercial insurance premiums rising faster than the inflation rate? And if so, is the employee portion of those premiums also rising, meaning a double whammy for employees' paychecks (ie, premium costs are getting bigger and bigger in an absolute sense, and also employees' relative share of those bigger costs is also bigger)? Spoiler alert: yes and yes. Chapter 2: What is the biggest reason for these premium increases? Like, if you look at the drivers of cost that underpin those rising premiums, what costs a lot that is making these premiums cost a lot? Spoiler alert: It's hospitals and the price increases at hospitals. And just in case anyone is wondering, this isn't, “Oh, chargemasters went up” or some kind of other tangential factor. We're talking about the revenue that hospitals are taking on services delivered has gone up and gone up way higher than the inflation rate. In fact, hospital costs have gone up over double the amount that premiums have gone up. Wait, what? That's a fact that Dr. Vivian Ho said today that threw my brain for a loop: Hospital costs have gone up over double the amount that premiums have gone up. Chapter 3: Is the reason that hospital prices have rocketed up as they have because the underlying costs these hospitals face are also going up way higher than the inflation rate? Like, for example, are nurses' salaries skyrocketing and doctors are getting paid a lot more than the inflation rate? Stuff like this. Too many eggs in the cafeteria. Way more charity care. Bottom line, is an increase in underlying costs the reason for rising hospital prices? Spoiler alert: no. No to all of the above. And I get into this deeply with Dr. Vivian Ho today. But before I do, I do just want to state with three underlines not all hospitals are the same. But yeah, you have many major consolidated hospitals crying about their, you know, “razor-thin margins” who are, it turns out, incentivizing their C-suites to do things that ultimately wind up raising prices. I saw a PowerPoint flying around—you may have seen it, too—that was apparently presented by a nonprofit hospital at JP Morgan, and it showed this nonprofit hospital with a 15.1% EBITDA (earnings before interest, taxes, depreciation, and amortization) in 2024. Not razor thin in my book. It's a, the boards of directors are structuring C-suite incentives in ways that ultimately will raise prices. If you want to dig in a little deeper on hospital boards and what they may be up to, listen to the show with Suhas Gondi, MD, MBA (EP404). Vivian Ho, PhD, my guest today, is a professor and faculty member at Rice University and Baylor College of Medicine. Her most major role these days is working on health policy at Baker Institute at Rice University. Her work there is at the national, state, and local levels conducting objective research that informs policymakers on how to improve healthcare. Today on the show, Professor Vivian Ho mentions research with Salpy Kanimian and Derek Jenkins, PhD. Alright, so just one quick sidebar before we get into the show. There is a lot going on with hospitals right now. So, before we kick in, let me just make one really important point. A hospital's contribution to medical research, like doing cancer clinical trials, is not the same as how a hospital serves or overcharges their community or makes decisions that increase or reduce their ability to improve the health and well-being of patients and members who wind up in or about the hospital. Huge, consolidated hospital networks can be doing great things that have great value and also, at the exact same time, kind of harmful things clinically and financially that negatively impact lots of Americans and doing all of that simultaneously. This is inarguable. Also mentioned in this episode are Rice University's Baker Institute for Public Policy; Baker Institute Center for Health Policy; Suhas Gondi, MD, MBA; Salpy Kanimian; Derek Jenkins, PhD; Byron Hugley; Michael Strain; Dave Chase; Zack Cooper, PhD; Houston Business Coalition on Health (HBCH); Marilyn Bartlett, CPA, CGMA, CMA, CFM; Cora Opsahl; Claire Brockbank; Shawn Gremminger; Autumn Yongchu; Erik Davis; Ge Bai, PhD, CPA; Community Health Choice; Mark Cuban; and Ferrin Williams, PharmD, MBA. For further reading, check out this LinkedIn post.   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho, PhD, is the James A. Baker III Institute Chair in Health Economics, a professor in the Department of Economics at Rice University, a professor in the Department of Medicine at Baylor College of Medicine, and a nonresident senior scholar in the USC Schaeffer Center for Health Policy and Economics. Ho's research examines the effects of economic incentives and regulations on the quality and costs of health care. Her research is widely published in economics, medical, and health services research journals. Ho's research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality, the American Cancer Society, and Arnold Ventures. Ho has served on the Board of Scientific Counselors for the National Center for Health Statistics, as well as on the NIH Health Services, Outcomes, and Delivery study section. She was elected as a member of the National Academy of Medicine in 2020. Ho is also a founding board member of the American Society for Health Economists and a member of the Community Advisory Board at Blue Cross Blue Shield of Texas. Ho received her AB in economics from Harvard University, a graduate diploma in economics from The Australian National University, and a PhD in economics from Stanford University.   05:12 Are insurance premiums going up? 05:59 What is the disparity between cost of insurance and wage increases? 06:21 LinkedIn post by Byron Hugley. 06:25 Article by Michael Strain. 06:46 How much have insurance premiums gone up for employers versus employees? 09:06 Chart showing the cost to insure populations of employees and families. 10:17 What is causing hospital prices and insurance premiums to go up so exponentially? 12:53 Article by (and tribute to) Uwe Reinhardt. 13:49 EP450 with Marilyn Bartlett, CPA, CGMA, CMA, CFM. 14:01 EP452 with Cora Opsahl. 14:03 EP453 with Claire Brockbank. 14:37 EP371 with Erik Davis and Autumn Yongchu. 15:28 Are razor-thin operating margins for hospitals causing these rising hospital prices? 16:56 Collaboration with Marilyn Bartlett and the NASHP Hospital Cost Tool. 19:47 What is the explanation that hospitals give for justifying these profits? 23:16 How do these hospital cost increases actually happen? 27:06 Study by Zack Cooper, PhD. 27:35 EP404 with Suhas Gondi, MD, MBA. 27:50 Who typically makes up a hospital board, and why do these motivations incentivize hospital price increases? 30:12 EP418 with Mark Cuban and Ferrin Williams, PharmD, MBA. 33:17 Why is it vital that change start at the board level?   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho discusses #healthinsurance #premiums and #hospitalpricing on our #healthcarepodcast. #healthcare #podcast #changemanagement #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Chris Crawford (EP465), Al Lewis, Betsy Seals, Wendell Potter (Encore! EP384), Dr Scott Conard, Stacey Richter (INBW42), Chris Crawford (EP461), Dr Rushika Fernandopulle, Bill Sarraille, Stacey Richter (INBW41)  

How do we ensure that healthcare is accessible, effective, efficient, and affordable for all? How can a professional society shape global health policy while advancing scientific research?In this episode of Associations Thrive, host Joanna Pineda interviews Rob Abbott, CEO of ISPOR. Rob discusses:ISPOR's role as the professional society for Health Economics and Outcomes Research (HEOR), with a global reach spanning over 100 countries and 20,000 members.How ISPOR is a multi-stakeholder society that includes clinicians, researchers, policymakers, industry professionals, and investors, creating a broad and impactful membership base.The importance of health economics and outcomes research in informing healthcare policy and improving patient outcomes worldwide.ISPOR's recent rebranding from the International Society for Pharmacoeconomics and Outcomes Research to ISPOR – The Professional Society for Health Economics and Outcomes Research, making the organization more inclusive of healthcare professionals.The launch of ISPOR's 2030 strategic plan, which features a bold vision for a world where healthcare is accessible, effective, efficient, and affordable for all.How ISPOR is shifting from primarily curating scientific research to actively engaging in health policy discussions and advocating for evidence-based decision-making.The upcoming launch of ISPOR's Institute for Global Health in 2025, which will focus on emerging healthcare challenges and horizon scanning for high-impact policy interventions.How ISPOR is strengthening its global chapters and partnerships to ensure local expertise informs global policy.The evolution of ISPOR's conferences, including record-breaking attendance and new events in Asia and Latin America to expand engagement in underserved regions.How ISPOR is working to redefine the concept of ‘value' in healthcare, incorporating social determinants of health and a more holistic approach to decision-making.References:ISPOR WebsiteMusic from #Uppbeat (free for Creators!):https://uppbeat.io/t/paul-yudin/quiet-flightLicense code: KJRRI6GHC7WKCLDT

In this episode of The MedTech Talent Lab, host Mitch Robbins sits down with April Spillane, VP of Market Access & Reimbursement at Intrinsic Therapeutics. With over 15 years in the industry—10 of those dedicated to spine—April shares her unique career trajectory, from clinical and business development to leading market access strategies at a high level.She opens up about the challenges of balancing a demanding career with motherhood, the leadership lessons she's learned along the way, and what it truly takes to thrive in market access and reimbursement. April also discusses the evolving healthcare landscape, the complexities of payer policies, and why persistence is key in the fight for patient access to cutting-edge technologies.Whether you're a MedTech leader, aspiring executive, or just curious about the behind-the-scenes battles to bring life-changing medical innovations to market, this episode is packed with valuable insights.Listen now to hear how April is shaping the future of MedTech access and advocacy!

If it benefits the health of the whole country, would you be willing to pay for someone else in Australia to lose weight? Ozempic, Wegovy and medications like them have revolutionised weight loss in Australia and around the world in the past few years, and both are now approved for treating diabetes and your taxpayer money goes towards subsidising their cost. But the Pharmaceutical Benefits Scheme has rejected funding them for weight loss. This means that people who are overweight but do not have diabetes are looking at hundreds of dollars a month if they want to try them to lose weight. On this episode of the Briefing, we’re asking – is that the right call? Bension Siebert is joined by Jonathan Karnon, Professor in Health Economics at Flinders University’s College of Medicine and Public Health, and Lauren Ball, Professor of Community Health and Wellbeing at The University of Queensland, to help answer the question. Follow The Briefing: TikTok: @listnrnewsroom Instagram: @listnrnewsroom @thebriefingpodcast YouTube: @LiSTNRnewsroom Facebook: @LiSTNR NewsroomSee omnystudio.com/listener for privacy information.

Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space.  In this instalment, Martin shares his thoughts on improving access to innovative cancer medicines, improving public trust toward the industry and his personal leadership style.  A little more on GOLD's guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and Africa, Johnson & Johnson, a role he has held for the past eight years. He leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Johnson & Johnson's new products and indications. Prior to this, Price worked in Johnson & Johnson's UK affiliate, latterly as director of external affairs, where he was responsible for market access, communications and government affairs. He joined Johnson & Johnson in 2001 from GlaxoSmithKline, where he began his career as senior health-outcomes manager. 

Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson.  In this first instalment of the conversation, Martin and Jade discuss this year's theme ‘United by Unique', the increasing importance of real-world evidence in oncology and improving access to innovative cancer medicines.   A little more on GOLD's guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and Africa, Johnson & Johnson, a role he has held for the past eight years. He leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Johnson & Johnson's new products and indications. Prior to this, Price worked in Johnson & Johnson's UK affiliate, latterly as director of external affairs, where he was responsible for market access, communications and government affairs. He joined Johnson & Johnson in 2001 from GlaxoSmithKline, where he began his career as senior health-outcomes manager.

Today, we are joined by Dr. Kathy Pearson and Dr. Gregg Pearson. Dr. Kathy Pearson, strategist, systems thinking expert, and decision-making authority, is President and Founder of Enterprise Learning Solutions. She is also an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics and has served as an adjunct Associate Professor in the Operations and Information Management Department at The Wharton School, both at the University of Pennsylvania. Kathy, an award-winning educator, collaborates with Executive Education groups and global organizations across industries like healthcare, finance, and technology, including clients such as Bank of America and Coca-Cola. She holds a BS in theoretical mathematics (Auburn University), an MS in Decision Sciences (Georgia State University), and a PhD in Industrial Engineering (Northwestern University). Dr. Gregg Pearson is a Partner at ELS and an Adjunct Professor of History at Lehigh University and La Salle University. He specializes in nineteenth-century American political history, twentieth-century American cultural history, military history, the history of technology, and business leadership. Gregg spent 16 years in the packaging industry, including as Northeast Region General Manager at Ball Corporation, overseeing $350M in revenue. He holds a PhD in History from Lehigh University, an MA from La Salle University, an MS in Industrial Engineering from Northwestern University, and is a graduate of the United States Military Academy at West Point. In this episode, we delve into the historical context of Abraham Lincoln's leadership during one of America's most tumultuous times. Key topics include: • Lincoln's assembly of a diverse cabinet • Lincoln's strategic decision-making process • The importance of diversity of thought and trust in leadership We also dive into how modern leaders can cultivate humility, leverage diverse perspectives, and build trust to make informed decisions and drive their organizations forward. Dr. Kathy Pearson and Dr. Gregg Pearson's Website: https://www.elslearning.com/ - Website and live online programs: http://ims-online.com Blog: https://blog.ims-online.com/ Podcast: https://ims-online.com/podcasts/ LinkedIn: https://www.linkedin.com/in/charlesagood/ Twitter: https://twitter.com/charlesgood99 Chapters: (00:00) Introduction (01:47) Historical Context (04:09) Lincoln's Leadership Challenges (05:33) Tool: Diversity of Thought in Leadership (07:56) Lincoln's Humility (11:08) Technique: Fort Sumter Crisis Strategy (13:34) Tip: Building Trust (16:21) Emancipation Proclamation Deliberations (20:34) Tip: Decision-Making in Leadership (24:42) Lincoln's Trust and Support (27:49) Lincoln's Legacy and Leadership Lessons (31:14) Conclusion

The brazen murder of UnitedHealthcare CEO Brian Thompson in broad daylight in midtown Manhattan last year has open the floodgates to an outpouring of anger and frustration with the health insurance industry. Across the country, whether it's about skyrocketing financial costs or access to care, there seems to be a wide agreement that health insurance in America is broken. The question is how to fix it. How can policy incentivize the industry to be better stewards of the health of its members without fueling unsustainable costs or incentivizing waste? What solutions are on the table and how might they shape the future of healthcare in America? Here to help us dig into the details is Vivian Ho, the James A. Baker III Institute Chair in Health Economics at Rice University.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The U.S. healthcare system is often described as one of the most advanced in the world, yet it’s also one of the most expensive and fragmented. Millions of Americans struggle with navigating insurance networks, surprise medical bills, and soaring costs. For many, accessing basic healthcare feels more like solving a puzzle than receiving care. So… why does the U.S. spend so much more on healthcare than other countries? What role do high prices, private insurance, and systemic inefficiencies play? And most importantly, what can we do to fix it? To help us unravel these questions, we’re joined by Mustafa Hussein, an Assistant Professor of Health Economics at the CUNY Graduate School of Public Health. Mustafa specializes in health inequalities, public policy, and the socio-economic drivers of health outcomes. Today – he discusses how our system got here and what it’ll take to create meaningful reform. See omnystudio.com/listener for privacy information.

There is a natural desire on the part of governments to ensure that their future citizens -- i.e. their nation's children -- are happy, healthy and productive, and that therefore governments have policies that work to achieve that. But good intentions never guarantee good policies. Here's where economist Janet Currie steps in. Currie is the Henry Putnam Professor of Economics and Public Affairs at Princeton University, where she co-directs, with Kate Ho, the Center for Health and Wellbeing. In this Social Science Bites podcast, the pioneer in assessing the nexus of policy and parenting explains to interviewer David Edmonds how programs like Head Start in the United States and Sure Start in the United Kingdom provide real benefits over time to both their young clients as youths and later on in life. After looking at a variety of programs and interventions, she details that "the general conclusion [is] that the programs that were spending more money directly on the children tended to have better outcomes." Her findings suggest this holds true even when similar approaches don't have the same effect on adults. "[I]n the United States," she says, "if you give health insurance to adults who didn't have health insurance, they use more services, and they are happier about that, that they get to use services. But it doesn't actually seem to save very much money. On the other hand, when you cover children from a young age, that is cost effective, that does save money, and in fact, the costs of the program probably pay for themselves in terms of the reduction in illness and disability going forward." In addition to her work at Princeton, Currie is also co-director of the National Bureau of Economic Research's Program on Families and Children. She has been president of the American Economic Association for 2024 and has also served as president of the American Society of Health Economics, the Society of Labor Economics, the Eastern Economic Association, and the Western Economic Association. Two years ago, she received the Klaus J. Jacobs Research Prize "for her foundational work on the influence of context such as policy decisions, environment, or health systems on child development."

In this episode, Becker's Healthcare's Erika Spicer Mason speaks with April Spillane, Vice President of Health Economics at Barricaid. April discusses the surge in outpatient spine procedures, the challenges and opportunities surrounding reimbursement, and how innovations like Barricaid are paving the way for wider access and improved patient care in ASC settings. This episode is sponsored by Barricaid. 

In this episode, Becker's Healthcare's Erika Spicer Mason speaks with April Spillane, Vice President of Health Economics at Barricaid. April discusses the surge in outpatient spine procedures, the challenges and opportunities surrounding reimbursement, and how innovations like Barricaid are paving the way for wider access and improved patient care in ASC settings. This episode is sponsored by Barricaid. 

Are you curious about the future of health and longevity? Join Dr. Tim Jackson as he chats with Dr. David Dror, a renowned health economist, about groundbreaking innovations in the longevity space. Discover how private investments are reshaping aging, the role of technology in extending lifespans, and the global impact of health systems on wellness. Tune in for an insightful dive into the intersection of health economics, aging, and the evolving science of living longer, healthier lives.   To connect with David DROR, read the EPISODE TRANSCRIPT, links mentioned in today's episode, and more, visit: https://healyourbody.org/longevity-frontiers-redefining-aging-and-health-economics-with-david-dror-ph-d-dba/ 

Australians have a sleeping problem. The most conservative estimates show one in 10 have a sleep disorder, which is having an impact on their safety, wellbeing and productivity.This ends up costing almost a $1 billion a week. And that's not all. The total cost of inadequate sleep is thought to be as high as $75 billion a year.We're not alone either. International research shows places like the US, the UK and Europe are facing similar problems, with similar costs.Guests:Shanthakumar Rajaratnam, Chair of the Sleep Health FoundationProfessor Ron Grunstein, The Woolcock Institute Wendy Troxel, The Rand CorporationZafina Ademi, Professor of Health Economics, Monash UniversityPresenter: Richard AedyProducer: Whitney Fitzsimons This program was first broadcast on 9th May, 2024

This piece was recorded at the The 7th Collaborative Clinical Trials in Anaesthesiology Conference, Prato, Italy. The discussion centers around the roles and contributions of bio statisticians in clinical trials. Presented by Kate Leslie and Andy Cumpstey with their guests, Jessica Kasza, Professor of Biostatistics, Data Analytics/Modelling and Health Economics at Monash University and Elizabeth Ryan, Research Fellow at Monash University.

Welcome back to the series, Perspectives on Peace, hosted by Chris Coyne. The first four episodes of this series will focus on The Legacy of Robert Higgs (Mercatus Center, 2024) and will feature a collection of short interviews with many of the chapter authors.This episode focuses on the military and health industrial complexes of Robert Higgs, featuring authors Nathan Goodman on “The Military-­Industrial Complex and the Militarization of Society”, Raymond March on “What About the Healthcare State? Robert Higgs's Contribution to Health Economics”, and Yuliya Yatsyshina on “The War Industry as Economic Cancer.” In their conversations, the authors share the impact Robert Higgs has had on their life and career and dive into a short summary of their respective chapters.Nathan P. Goodman is a Senior Research Fellow and Senior Fellow at the F.A. Hayek Program for Advanced Study in Philosophy, Politics, and Economics at the Mercatus Center at George Mason University. Nathan is an alum of the Mercatus PhD Fellowship.Raymond J. March is an Assistant Professor of Economics at Angelo State University.Yuliya Yatsyshina is an Associate Program Director for Academic & Student Programs at the Mercatus Center at George Mason University. Yuliya is an alum of the Mercatus MA Fellowship.Learn more about Chris Coyne's work as Director of the Initiative for the Study of a Stable Peace (ISSP).If you like the show, please subscribe, leave a 5-star review, and tell others about the show! We're available on Apple Podcasts, Spotify, Amazon Music, and wherever you get your podcasts.Virtual Sentiments, our new podcast series from the Hayek Program is streaming! Subscribe today and listen to seasons one and two.Follow the Hayek Program on Twitter: @HayekProgramLearn more about Academic & Student ProgramsFollow the Mercatus Center on Twitter: @mercatusCC Music: Twisterium

Rob Abbott, CEO and Executive Director at ISPOR, the Professional Society for Health Economics and Outcomes Research, focuses on defining and measuring value in healthcare, including accessibility, affordability, effectiveness, and patient outcomes. HEOR (health economics and outcomes research) can provide data-driven insights to guide healthcare decision-making, reduce bias in research, and consider a broader range of factors like social determinants of health. This can improve treatment adherence, align therapies with what matters most to patients, and support the evaluation of technology used for treatments and predictive analysis of new therapies.   Rob explains, "I'm excited at both the legacy of work that health economics and outcomes research has contributed to, but I'm particularly excited about the extent to which health economics and outcomes research can provide data-driven insights to highlight health interventions that provide the best health outcomes for the investment made. This is good for managing the expenditure of public resources. Still, even more so, data-driven insights can help us lead to better health outcomes, better treatment protocols, and better health outcomes for patients." "As health economists and a professional society representing health economists and outcomes researchers, I think we know that historically, we have defined value quite narrowly in terms of a person's physical health, for instance. But we know that increasingly the concept of whole health or a more holistic approach to health is gaining a lot of traction. So, we are actively engaged in expanding the definition of health to include access to housing, social connections and networks, healthy food and lifestyle choices, and things of that nature. So, I think we are beginning to bring some new ideas to the table in terms of how we think about health."  #ISPOR #Patients #Healthcare #DigitalHealth #GlobalHealth #HEOR #RWE #HealthEconomics #HealthAI #DrugPriceNegotiations ISPOR.org Listen to the podcast here

Welcome to the No Labels, No Limits podcast! Today we have Dr. Schroeter, a trailblazing Ph.D. in Health Economics, who is revolutionizing wellness coaching through an innovative mix of gamification and storytelling. Dr. Schroeter's approach is designed to help women overcome low self-esteem and build confidence, transforming their health and success in both personal and professional realms.In this episode, we'll dive into:Innovative Wellness Tips: Discover actionable strategies for making healthy snacks more accessible and incorporating petite practices into your busy life. Learn how small, manageable changes can lead to significant improvements in your overall well-being.Gamification Fun: Explore how gamification can make adopting new wellness habits a fun and rewarding experience. From setting playful challenges to tracking progress with a game-like approach, find out how to make self-care engaging and enjoyable.Visual Strategies: Get creative with visual techniques that make your wellness journey more engaging. Learn how to use visual cues, reminders, and fun visuals to keep you motivated and excited about your health goals.Join us and discover a refreshing approach to wellness that fits seamlessly into your busy life. With Dr. Schroeter's innovative strategies and playful techniques, you'll find new ways to nurture your health and confidence while having fun along the way. Tune in to unlock practical tips, inspiring stories, and engaging games that make self-care both achievable and enjoyable. Embrace a happier, healthier you and turn every day into a new opportunity for growth and success.Dr. Schroeter reminds us that "Stepping out of your comfort zone can lead to the most unexpected and rewarding adventures. Ooh la la!"Don't miss out—subscribe now and start your journey towards a more vibrant life today!Gift: Petite Practice Planner Hello Happy Nest | Business & Wellness CoachConnect and Learn more with Christiane Schroeter: Website: Hello Happy Nest | Business & Wellness CoachInstagram: https://www.instagram.com/hello.happy.nest/Podcast: https://hellohappynest.com/podcast/YouTube: https://www.youtube.com/@hellohappynestFacebook: https://www.facebook.com/HelloHappyNestTikTok: https://www.tiktok.com/@hello.happy.nestLinkedIn: https://www.linkedin.com/in/christianeschroeter/Connect and Learn more with Sarah Boxx: The SandBoxx offers Nonprofit business consulting and coaching for leaders. (sarahboxx.com)#WellnessJourney #HealthyLiving #HealthAndWellness #HealthyHabits #NLNL Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

My conversation today is with Will Shrank, MD. Dr. Shrank led the evaluation group at CMMI (Center for Medicare and Medicaid Innovation). He has spent time in the private sector, first at CVS Health and UPMC (University of Pittsburgh Medical Center) as chief medical officer of the health plan in Pittsburgh, and then as the chief medical officer for Humana. Now he is a venture partner at Andreessen Horowitz and doing some consulting for CMMI. To read the full article and show notes which include mentioned links, visit the episode page.  If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. We start out this conversation talking about waste in healthcare. In fact, Dr. Shrank was on a team who did a study about waste in the US healthcare system. (The article is, unfortunately, paywalled.) In that study, it says estimates suggest we have upwards of a trillion dollars of waste a year. This waste can be categorized into administrative and clinical failures. Dr. Shrank emphasizes the need for aligning incentives with higher quality care, paying for patient outcomes, and highlights the potential rising power of PCPs. The discussion covers the progress made towards value-based care, the challenges faced by the current fee-for-service model, and the future landscape of primary care and healthcare delivery. In sum, we have a waste problem in this country. Aligning incentives might be one way to curb that waste. 06:54 Can we cut healthcare waste while improving patient care? 07:33 What does “healthcare waste” consist of? 07:46 What are the six categories of “healthcare waste”? 10:23 EP363 with David Scheinker, PhD. 10:37 How much money does Dr. Shrank estimate is wasted each year in healthcare? 13:09 Where is that healthcare waste going, and why does it happen? 20:07 Uncaring by Robert Pearl, MD. 21:18 “We've built a backbone of extraordinary waste on a fee-for-service chassis.” 22:16 EP409 with Larry Bauer, MSW, MEd. 24:24 EP359 with Dan O'Neill. 26:02 Dr. Shrank's warning to providers out there. 30:03 Summer Shorts 2 with Scott Conard, MD. 31:41 Why there might be a generational shift among younger providers looking to work with different models.

Since the start of the pandemic (and really, before that), frontline healthcare workers have been rightfully lauded for the tireless work that they have done to keep the healthcare system from cratering in this country. This is no easy task, as we have seen the devastation that the pandemic has wrought among our communities, and especially within the healthcare field. In Southern California, the cost of living crisis has filtered into the workplace, with many healthcare workers finding themselves priced out of their neighborhoods due to rising costs and unchecked gentrification, their stagnant wages and dwindling access to healthcare benefits compounding an already untenable situation. More than 2,200 healthcare workers at Keck Medicine at the University of Southern California are fighting for improved working conditions and a chance to combat the cost of living crisis with a new contract. So far, they have been met with an aggressive management that is hellbent on freezing wages and striking some of the most important benefits that healthcare workers enjoy from the contract. Represented by the National Union of Healthcare Workers, or NUHW, these workers - medical technicians, respiratory therapists, licensed vocational nurses, housekeepers and nursing assistants - have made clear their demands for improved working conditions at multiple USC healthcare facilities across Los Angeles, and we've brought on Francisco Cendejas and Noemi Aguirre, two worker-organizers at Keck Medicine, to talk about the ongoing contract negotiations.Note: This episode was recorded on July 18th, 2024. Negotiations with Keck-USC are still ongoing.Additional links/info below…NUHW - Keck-USC Negotiations FactsheetPenn Leonard Davis Institute of Health Economics, “How Inadequate Hospital Staffing Continues to Burn Out Nurses and Threaten Patients”National Union of Healthcare Workers - Main SitePermanent links below...Leave us a voicemail and we might play it on the show!Labor Radio / Podcast Network website, Facebook page, and Twitter pageIn These Times website, Facebook page, and Twitter pageThe Real News Network website, YouTube channel, podcast feeds, Facebook page, and Twitter pageFeatured Music...Jules Taylor, "Working People" Theme SongHelp us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Sign up for our newsletterLike us on FacebookFollow us on TwitterDonate to support this podcast